Exact Mass: 386.2609514
Exact Mass Matches: 386.2609514
Found 500 metabolites which its exact mass value is equals to given mass value 386.2609514,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Bufalin
Bufalin is a cardiotonic steroid toxin[1] originally isolated from Chinese toad venom, which is a component of some traditional Chinese medicines.[2][3] Bufalin has in vitro antitumor effects against various malignant cell lines, including hepatocellular[4] and lung carcinoma.[5] However, as with other bufadienolides, its potential use is hampered by its cardiotoxicity.[6] Bufalin is a 14beta-hydroxy steroid that is bufan-20,22-dienolide having hydroxy substituents at the 5beta- and 14beta-positions. It has been isolated from the skin of the toad Bufo bufo. It has a role as an antineoplastic agent, a cardiotonic drug, an anti-inflammatory agent and an animal metabolite. It is a 3beta-hydroxy steroid and a 14beta-hydroxy steroid. It is functionally related to a bufanolide. Bufalin is a natural product found in Cunninghamella blakesleeana, Bufo gargarizans, and other organisms with data available. Bufalin is an active ingredient and one of the glycosides in the traditional Chinese medicine ChanSu; it is also a bufadienolide toxin originally isolated from the venom of the Chinese toad Bufo gargarizans, with potential cardiotonic and antineoplastic activity. Although the mechanism of action of bufalin is still under investigation, this agent is a specific Na+/K+-ATPase inhibitor and can induce apoptosis in cancer cell lines through the activation of the transcription factor AP-1 via a mitogen activated protein kinase (MAPK) pathway. A 14beta-hydroxy steroid that is bufan-20,22-dienolide having hydroxy substituents at the 5beta- and 14beta-positions. It has been isolated from the skin of the toad Bufo bufo. Bufalin is an active component isolated from Chan Su, acts as a potent Na+/K+-ATPase inhibitor, binds to the subunit α1, α2 and α3, with Kd of 42.5, 45 and 40 nM, respectively[1][2]. Anti-cancer activity[2]. Bufalin is an active component isolated from Chan Su, acts as a potent Na+/K+-ATPase inhibitor, binds to the subunit α1, α2 and α3, with Kd of 42.5, 45 and 40 nM, respectively[1][2]. Anti-cancer activity[2].
Testosterone Isocaproate
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
Medroxyprogesteroneacetate
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents CONFIDENCE standard compound; INTERNAL_ID 8749 CONFIDENCE standard compound; INTERNAL_ID 2813 D000970 - Antineoplastic Agents Medroxyprogesterone acetate is a widely used synthetic steroid by its interaction with progesterone, androgen and glucocorticoid receptors[1]. Medroxyprogesterone acetate is a widely used synthetic steroid by its interaction with progesterone, androgen and glucocorticoid receptors[1].
Oleandolide
A 14-membererd macrolide containing ten stereocentres carrying one epoxymethano, three hydroxy and five methyl substituents. It is the aglycone of the antibiotic oleandomycin.
12a-Hydroxy-3-oxocholadienic acid
12a-Hydroxy-3-oxocholadienic acid is a bile acid. Bile acids are steroid acids found predominantly in the bile of mammals. The distinction between different bile acids is minute, depending only on the presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g. membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues (PMID: 11316487, 16037564, 12576301, 11907135). A bile acid. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12.
Luffariellolide
Mangalkanyl glucoside
Mangalkanyl glucoside is found in fruits. Mangalkanyl glucoside is a constituent of the root bark of Mangifera indica (mango) Constituent of the root bark of Mangifera indica (mango). Mangalkanyl glucoside is found in fruits.
Cryptomeridiol 11-rhamnoside
Cryptomeridiol 11-rhamnoside is a constituent of fruits of Cananga odorata (ylang ylang). Constituent of fruits of Cananga odorata (ylang ylang)
10,11-dihydro-20-trihydroxy-leukotriene B4
10,11-dihydro-20-trihydroxy-leukotriene B4 is the metabolite of lipid omega-oxidation of leukotriene B4 (LTB4). LTB4 is the major metabolite in neutrophil polymorphonuclear leukocytes. Omega-oxidation is the major pathway for the catabolism of leukotriene B4 in human polymorphonuclear leukocytes. Leukotrienes are metabolites of arachidonic acid derived from the action of 5-LO (5-lipoxygenase). The immediate product of 5-LO is LTA4 (leukotriene A4), which is enzymatically converted into either LTB4 (leukotriene B4) by LTA4 hydrolase or LTC4 (leukotriene C4) by LTC4 synthase. The regulation of leukotriene production occurs at various levels, including expression of 5-LO, translocation of 5-LO to the perinuclear region, and phosphorylation to either enhance or inhibit the activity of 5-LO. Biologically active LTB4 is metabolized by omega-oxidation carried out by specific cytochrome P450s (CYP4F) followed by beta-oxidation from the omega-carboxy position and after CoA ester formation (PMID: 7649996, 17623009, 2853166, 6088485). Leukotrienes are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs), and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes), and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signalling pathways. 10,11-Dihydro-20-trihydroxy-leukotriene B4 is the metabolite of lipid omega-oxidation of leukotriene B4 (LTB4). LTB4 is the major metabolite in neutrophil polymorphonuclear leukocytes. Omega-oxidation is the major pathway for the catabolism of leukotriene B4 in human polymorphonuclear leukocytes. Leukotrienes are metabolites of arachidonic acid derived from the action of 5-LO (5-lipoxygenase). The immediate product of 5-LO is LTA4 (leukotriene A4), which is enzymatically converted into either LTB4 (leukotriene B4) by LTA4 hydrolase or LTC4 (leukotriene C4) by LTC4 synthase. The regulation of leukotriene production occurs at various levels, including expression of 5-LO, translocation of 5-LO to the perinuclear region and phosphorylation to either enhance or inhibit the activity of 5-LO. Biologically active LTB4 is metabolized by w-oxidation carried out by specific cytochrome P450s (CYP4F) followed by beta-oxidation from the w-carboxy position and after CoA ester formation. (PMID: 7649996, 17623009, 2853166, 6088485)
9'-Carboxy-alpha-tocotrienol
9-Carboxy-alpha-tocotrienol is a dehydrogenation carboxylate product of 9-hydroxy-a-tocotrienol by an unidentified microsomal enzyme(s) probably via an aldehyde intermediate. Tocotrienols are members of the vitamin E family. An essential nutrient for the body, vitamin E is made up of four tocopherols (alpha, beta, gamma, delta) and four tocotrienols (alpha, beta, gamma, delta).Chemically, vitamin E is an antioxidant. One model for the function of vitamin E in the body is that it protects cell membranes, active enzyme sites, and DNA from free radical damage. Tocotrienols are natural compounds found in select vegetable oils, wheat germ, barley, saw palmetto, and certain types of nuts and grains. This variant of vitamin E only occur at very low levels in nature. While the majority of research on vitamin E has focused on alpha-tocopherol, studies into tocotrienols account for less than 1\\% of all research into vitamin E. 9-Carboxy-alpha-tocotrienol is a dehydrogenation carboxylate product of 9-hydroxy-a-tocotrienol by an unidentified microsomal enzyme(s) probably via an aldehyde intermediate
Glycerol trihexanoate
Glycerol trihexanoate is a probable constituent of fat Probable constituent of fats.
N-Lauroyl Tryptophan
N-lauroyl tryptophan belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Lauric acid amide of Tryptophan. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Lauroyl Tryptophan is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Lauroyl Tryptophan is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.
(Z)-7-[(1R,2R,3R,5S)-2-(1,2-Dihydroxy-3-oxooctyl)-3,5-dihydroxycyclopentyl]hept-5-enoic acid
Aragest
bufalin
Dexanabinol
Proligestone
1-[Fluoro(methoxy)phosphoryl]oxyicosa-5,8,11,14-tetraene
C21H36FO3P (386.23859680000004)
Ophiobolin C
A sesterterpenoid that is ophiobolane with a hydroxy group at position 3, oxo group at positions 5, formyl group at position 7, and double bonds at positions 7-8 and 19-20.
N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-((4-hydroxycyclohexyl)methyl)-1h-indazole-3-carboxamide
C21H30N4O3 (386.23177899999996)
(3beta,20S)-3-Hydroxy-4,4,14-trimethylpregna-7,9(11)-diene-20-carboxylic acid|3beta-hydroxy-4,4,14alpha-trimethyl-5alpha-pregna-7,9(11)-diene-20S-carboxylic acid
N-(3-hydroxyisotetradecanoyl)anatabine
C24H38N2O2 (386.29331279999997)
1-acetyl-16-methoxy-aspidospermidine-17,21-diol|3-Methoxy-limapodin
(1R,2R,4R)-4-isobutyl-6,6,8,8-tetramethyl-2,3,4,8-tetrahydrochromene-5,7-dione-2-spiro-2-6,6-dimethyl-bicyclo[3.1.1]heptane|ficifolidione
(ent-15beta)-2-Methylpropenoyl-15-Hydroxy-16-kauren-19-oic acid|2-Methylpropenoyl-15-Hydroxy-16-kauren-19-oic acid
4-(1-methoxyethyl)-5-methyl-2-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl]benzene-1,3-diol
20-(N,N-dimethylamino)-3beta-(N-formylamino)-5alpha-pregn-2-en-4-one|hookerianamide H
C24H38N2O2 (386.29331279999997)
6beta-cinnamoyloxy-1beta,4alpha-dihydroxyeudesmane
3,17-dimethyl-18,19-dinor-17alpha-stigmasta-1,3,5,7,9,11,13-heptaene
Bourgeanic-Acid|Bourgeanic-saeure|xanthoric acid B
3beta,7beta,8beta,12zeta,17-pentahydroxylabdan-16,15-olide
(3E,11E)-6,19-epoxy-17,20-dihydroxycembra-3,6,8(19),11,15-pentaene 17-butanoate
3beta,16beta-dihydroxy-5beta,14alpha-bufa-20,22-dienolide
3-(4,8,12,16-tetramethylheptadeca-3,7,11,15-tetraenyl)thiophene-1-oxide
1-[(7beta)-11,12-dihydroxy-15-methoxyabieta-5,8,11,13-tetraen-7-yl]propan-2-one|isolophanthin D
15,16-dihydroxy-9Z,12Z-octadecadienoic acid 2,3-dihydroxypropyl ester
(+)-17-hydroxyemericella-3E,7E,12Z,22-tetraen-16-oic acid|emericellene C
3-oxo-24,25,26,27,29-pentnor-5alpha-cycloart-23,21-olide|aphagrandinoid C
(+)-emericella-3E,7E,22-trien-17alpha-al-16-oic acid|emericellene D
(3beta,5beta)-methyl (3-hydroxy-20-oxo-21-norcholan-14,16-dien-24-oate)
1-acetoxy-5-methyl-2-[(2E,7Z)-3,7,11-trimethyl-2,7-dodecadien-9-onyl]-4-hydroxybenzene
(+)-12beta,17-epoxyemericella-3E,7E,22-trien-16-oic acid|emericellene B
2-hydroxy-5-methoxy-3-[8Z,11Z,14Z-heptadecatriene]-p-benzoquinone|sorgoleone-386
(20R,24R)-4,17beta-Dimethyl-18,19-dinorstigmast-1,3,5,7,9,11,13-heptaene
4beta,9beta-dihydroxy-6beta-cinnamoyloxy-eudesmane
(3E,11E)-6,19-epoxy-17,20-dihydroxycembra-3,6,8(19),11,15-pentaene 20-butanoate
12-deacetoxy-12-oxo-deoxoscalarin|12-deacetoxy-12-oxodeoxoscalarin|12-ketodeoxoscalarin
4-O-methylgrifolic acid|Grifolic acid methyl ether
Medroxyprogesterone acetate
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents D000970 - Antineoplastic Agents Medroxyprogesterone acetate is a widely used synthetic steroid by its interaction with progesterone, androgen and glucocorticoid receptors[1]. Medroxyprogesterone acetate is a widely used synthetic steroid by its interaction with progesterone, androgen and glucocorticoid receptors[1].
MLS000069442-01!MEDROXYPROGESTERONE ACETATE520-85-4
2-[5-[2-[2-[5-(2-hydroxypropyl)oxolan-2-yl]propanoyloxy]propyl]oxolan-2-yl]propanoic acid
5-[12-(3,5-dihydroxyphenyl)dodecyl]benzene-1,3-diol
2-[5-[2-[2-[5-(2-hydroxypropyl)oxolan-2-yl]propanoyloxy]propyl]oxolan-2-yl]propanoic acid
2-[5-[2-[2-[5-(2-hydroxypropyl)oxolan-2-yl]propanoyloxy]propyl]oxolan-2-yl]propanoic acid [IIN-based: Match]
2-[5-[2-[2-[5-(2-hydroxypropyl)oxolan-2-yl]propanoyloxy]propyl]oxolan-2-yl]propanoic acid [IIN-based on: CCMSLIB00000845048]
2-[5-[2-[2-[5-(2-hydroxypropyl)oxolan-2-yl]propanoyloxy]propyl]oxolan-2-yl]propanoic acid [IIN-based on: CCMSLIB00000845049]
2-[5-[2-[2-[5-(2-hydroxypropyl)oxolan-2-yl]propanoyloxy]propyl]oxolan-2-yl]propanoic acid_major
2-[5-[2-[2-[5-(2-hydroxypropyl)oxolan-2-yl]propanoyloxy]propyl]oxolan-2-yl]propanoic acid_minor
Ala Ala Ile Ile
Ala Ala Ile Leu
Ala Ala Leu Ile
Ala Ala Leu Leu
Ala Ile Ala Ile
Ala Ile Ala Leu
Ala Ile Ile Ala
Ala Ile Leu Ala
Ala Ile Pro Ser
Ala Ile Ser Pro
Ala Leu Ala Ile
Ala Leu Ala Leu
Ala Leu Ile Ala
Ala Leu Leu Ala
Ala Leu Pro Ser
Ala Leu Ser Pro
Ala Pro Ile Ser
Ala Pro Leu Ser
Ala Pro Ser Ile
Ala Pro Ser Leu
Ala Pro Thr Val
Ala Pro Val Thr
Ala Ser Ile Pro
Ala Ser Leu Pro
Ala Ser Pro Ile
Ala Ser Pro Leu
Ala Thr Pro Val
Ala Thr Val Pro
Ala Val Pro Thr
Ala Val Thr Pro
Ala Val Val Val
Gly Ile Pro Thr
Gly Ile Thr Pro
Gly Ile Val Val
Gly Leu Pro Thr
Gly Leu Thr Pro
Gly Leu Val Val
Gly Pro Ile Thr
Gly Pro Leu Thr
Gly Pro Thr Ile
Gly Pro Thr Leu
Gly Thr Ile Pro
Gly Thr Leu Pro
Gly Thr Pro Ile
Gly Thr Pro Leu
Gly Val Ile Val
Gly Val Leu Val
Gly Val Val Ile
Gly Val Val Leu
Ile Ala Ala Ile
Ile Ala Ala Leu
Ile Ala Ile Ala
Ile Ala Leu Ala
Ile Ala Pro Ser
Ile Ala Ser Pro
Ile Gly Pro Thr
Ile Gly Thr Pro
Ile Gly Val Val
Ile Ile Ala Ala
Ile Leu Ala Ala
Ile Pro Ala Ser
Ile Pro Gly Thr
Ile Pro Ser Ala
Ile Pro Thr Gly
Ile Ser Ala Pro
Ile Ser Pro Ala
Ile Thr Gly Pro
Ile Thr Pro Gly
Ile Val Gly Val
Ile Val Val Gly
Leu Ala Ala Ile
Leu Ala Ala Leu
Leu Ala Ile Ala
Leu Ala Leu Ala
Leu Ala Pro Ser
Leu Ala Ser Pro
Leu Gly Pro Thr
Leu Gly Thr Pro
Leu Gly Val Val
Leu Ile Ala Ala
Leu Leu Ala Ala
Leu Pro Ala Ser
Leu Pro Gly Thr
Leu Pro Ser Ala
Leu Pro Thr Gly
Leu Ser Ala Pro
Leu Ser Pro Ala
Leu Val Gly Val
Leu Val Val Gly
Val Ala Val Val
Val Gly Ile Val
Val Gly Leu Val
Val Gly Val Ile
Val Gly Val Leu
Val Ile Gly Val
Val Ile Val Gly
Val Leu Gly Val
Val Leu Val Gly
Val Val Ala Val
Val Val Gly Ile
Val Val Gly Leu
Val Val Ile Gly
Val Val Leu Gly
Val Val Val Ala
(22E)-1α,3β-Dihydroxychola-5,16,22-trien-24-oic Acid
3α-Hydroxy-12-oxo-5β-chola-7,9(11)-dien-24-oic Acid
HU-211
Tricaproin
A triglyceride obtained by condensation of each of the three hydroxy groups of glycerol with hexanoic (caproic) acid.
Cryptomeridiol 11-rhamnoside
hu-210
D018377 - Neurotransmitter Agents > D018683 - Excitatory Amino Acid Agents > D018691 - Excitatory Amino Acid Antagonists D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D005765 - Gastrointestinal Agents > D000932 - Antiemetics D020011 - Protective Agents
ascr#25
An (omega-1)-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of (2E,14R)-14-hydroxypentadec-2-enoic acid with ascarylopyranose (the alpha anomer). It is a metabolite of the nematode Caenorhabditis elegans.
oscr#25
An omega-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of (2E)-15-hydroxypentadec-2-enoic acid with ascarylopyranose (the alpha anomer). It is a metabolite of the nematode Caenorhabditis elegans.
3-hydroxy-4-methylene-2-(n-eicos-11-yn-19-enyl)but-2-enolide
2-ethyl-2-[[(1-oxopentyl)oxy]methyl]propane-1,3-diyl divalerate
Proligestone
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
2,5-Dihexyl-1,4-benzene-diboronic acid ethylene glycol ester
C22H36B2O4 (386.27995560000005)
[(8S,10S,13S,14S,17R)-17-acetyl-17-hydroxy-10,13,16-trimethyl-1,2,3,4,5,6,7,8,12,14-decahydrocyclopenta[a]phenanthren-3-yl] acetate
1,1,4,4,7,7,10,10-OCTAMETHYL-2,3,4,7,8,9,10,12-OCTAHYDRO-1H-DIBENZO[B,H]FLUORENE
N-(2-aminoethyl)ethane-1,2-diamine,2-(chloromethyl)oxirane,hexanedioic acid,N-methylmethanamine
C15H35ClN4O5 (386.22958500000004)
buta-1,3-diene,butyl prop-2-enoate,methyl 2-methylprop-2-enoate,styrene
1-(DODECYLOXY)-4-((4-ETHYNYLPHENYL)ETHYNYL)BENZENE
Pregn-4-ene-3,20-dione,17-(acetyloxy)-6-methyl-, (6b)- (9CI)
3β-Acetoxy-16α,17α-epoxy-16β-methyl-5α-pregn-9-en-20-on
butyl 2-methylprop-2-enoate,2-hydroxypropyl 2-methylprop-2-enoate,methyl 2-methylprop-2-enoate
16α,17α-Epoxy-16β-methyl-Δ5-pregnen-3β-ol-20-on-3-acetat
Algestone acetonide
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
1-Butyl-8-(3-noradamantyl)-3-(3-hydroxypropyl)xanthine
C21H30N4O3 (386.23177899999996)
PSB36 is a potent and selective antagonist of adenosine A1 receptor, with Kis 0.12 nM, 187 nM, 552 nM, 2300 nM, and 6500 nM for rA1, hA2B, rA2A, hA3 and rA3 receptors respectively. PSB36 can be used for the research of hyperalgesia[1][2].
hookerianamide H
C24H38N2O2 (386.29331279999997)
A steroid alkaloid that is 5alpha-pregn-2-ene-4-one substituted by a N-formylamino group at position 3 and a N,N-dimethylamino group at position 20. Isolated from Sarcococca hookeriana, it exhibits antiplasmodial activity and inhibitory activity against cholinesterase.
(2E,14R)-14-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]pentadec-2-enoic acid
(2E)-15-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]pentadec-2-enoic acid
N-(4,6-dimethyl-2-pyrimidinyl)-1,3-bis(phenylmethyl)-2,4-dihydro-1,3,5-triazin-6-amine
(8R)-8-({3,6-dideoxy-4-O-[(2E)-2-methylbut-2-enoyl]-alpha-L-arabino-hexopyranosyl}oxy)nonanoic acid
2,5-Cyclohexadiene-1,4-dione, 2,3-dimethoxy-5-methyl-6-(3,7,11-trimethyl-2,6,10-dodecatrienyl)-, (E,E)-
Dexanabinol
D018377 - Neurotransmitter Agents > D018683 - Excitatory Amino Acid Agents > D018691 - Excitatory Amino Acid Antagonists C274 - Antineoplastic Agent > C129839 - Apoptotic Pathway-targeting Antineoplastic Agent D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D005765 - Gastrointestinal Agents > D000932 - Antiemetics C26170 - Protective Agent > C1509 - Neuroprotective Agent D020011 - Protective Agents
(1s,3r,4s,5s,7s)-4-{[2-(4-Methoxyphenoxy)-2-Methylpropanoyl]amino}adamantane-1-Carboxamide
(S)-N-(4-Carbamimidoylbenzyl)-1-(2-(Cyclohexyloxy)ethanoyl)pyrrolidine-2-Carboxamide
C21H30N4O3 (386.23177899999996)
1-[Fluoro(methoxy)phosphoryl]oxyicosa-5,8,11,14-tetraene
C21H36FO3P (386.23859680000004)
[(2R)-3-carboxy-2-[(Z)-3-hydroxytetradec-5-enoyl]oxypropyl]-trimethylazanium
C21H40NO5+ (386.29063300000007)
[3-Carboxy-2-(3-oxotetradecanoyloxy)propyl]-trimethylazanium
C21H40NO5+ (386.29063300000007)
[3-carboxy-2-[(E)-12-carboxydodec-8-enoyl]oxypropyl]-trimethylazanium
C20H36NO6+ (386.25424960000004)
[3-carboxy-2-[(E)-12-carboxydodec-10-enoyl]oxypropyl]-trimethylazanium
C20H36NO6+ (386.25424960000004)
[3-carboxy-2-[(E)-12-carboxydodec-11-enoyl]oxypropyl]-trimethylazanium
C20H36NO6+ (386.25424960000004)
[3-carboxy-2-[(E)-12-carboxydodec-6-enoyl]oxypropyl]-trimethylazanium
C20H36NO6+ (386.25424960000004)
[3-carboxy-2-[(E)-12-carboxydodec-9-enoyl]oxypropyl]-trimethylazanium
C20H36NO6+ (386.25424960000004)
[3-carboxy-2-[(E)-9-hydroxytetradec-6-enoyl]oxypropyl]-trimethylazanium
C21H40NO5+ (386.29063300000007)
[3-carboxy-2-[(E)-10-hydroxytetradec-12-enoyl]oxypropyl]-trimethylazanium
C21H40NO5+ (386.29063300000007)
[3-carboxy-2-[(E)-5-hydroxytetradec-3-enoyl]oxypropyl]-trimethylazanium
C21H40NO5+ (386.29063300000007)
[3-carboxy-2-[(E)-8-hydroxytetradec-5-enoyl]oxypropyl]-trimethylazanium
C21H40NO5+ (386.29063300000007)
[3-carboxy-2-[(E)-4-hydroxytetradec-2-enoyl]oxypropyl]-trimethylazanium
C21H40NO5+ (386.29063300000007)
(E)-7-[2-(1,2-dihydroxy-3-oxooctyl)-3,5-dihydroxycyclopentyl]hept-5-enoic acid
[(E)-2-(carboxymethyl)-2,16-dihydroxy-3-oxohexadec-4-enyl]-trimethylazanium
C21H40NO5+ (386.29063300000007)
[(6S,10R,13S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate
(10aS)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c][1]benzopyran-1-ol
8-[4-(2,3-Dihydro-1,4-benzodioxin-3-ylmethylamino)butyl]-8-azaspiro[4.5]decane-7,9-dione
1-[2-(4-methylphenyl)ethyl]-N-[3-(4-methyl-1-piperazinyl)propyl]-5-oxo-3-pyrrolidinecarboxamide
(1R,2R,6R)-3-methyl-5-oxo-6-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]-7-oxabicyclo[4.1.0]hept-3-en-2-yl acetate
2-[2-[[5-[1-(Dimethylamino)propyl]-4-[2-(4-morpholinyl)ethyl]-1,2,4-triazol-3-yl]thio]ethylamino]ethanol
1-Cyclohexyl-4-[1-[1-[(4-fluorophenyl)methyl]-5-tetrazolyl]propyl]piperazine
C21H31FN6 (386.25940979999996)
(4R,7R)-4-[(4-methoxyphenyl)methyl]-7-(2-methylpropyl)-9-oxa-1,6,12,13-tetrazabicyclo[9.2.1]tetradeca-11(14),12-dien-5-one
C21H30N4O3 (386.23177899999996)
(4S,7S)-4-[(4-methoxyphenyl)methyl]-7-(2-methylpropyl)-9-oxa-1,6,12,13-tetrazabicyclo[9.2.1]tetradeca-11(14),12-dien-5-one
C21H30N4O3 (386.23177899999996)
(5S,8S)-8-[(4-methoxyphenyl)methyl]-5-(2-methylpropyl)-3-oxa-1,6,13,14-tetrazabicyclo[9.3.0]tetradeca-11,13-dien-7-one
C21H30N4O3 (386.23177899999996)
N-[[(2R,3S,4S)-1-[cyclobutyl(oxo)methyl]-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-N-(2-methylpropyl)propanamide
N-[[(2R,3R,4R)-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-2-methoxy-N-propan-2-ylacetamide
5-[12-(3,5-Dihydroxyphenyl)dodecyl]benzene-1,3-diol
(4S,7R)-4-[(4-methoxyphenyl)methyl]-7-(2-methylpropyl)-9-oxa-1,6,12,13-tetrazabicyclo[9.2.1]tetradeca-11(14),12-dien-5-one
C21H30N4O3 (386.23177899999996)
(4R,7S)-4-[(4-methoxyphenyl)methyl]-7-(2-methylpropyl)-9-oxa-1,6,12,13-tetrazabicyclo[9.2.1]tetradeca-11(14),12-dien-5-one
C21H30N4O3 (386.23177899999996)
(5S,8R)-8-[(4-methoxyphenyl)methyl]-5-(2-methylpropyl)-3-oxa-1,6,13,14-tetrazabicyclo[9.3.0]tetradeca-11,13-dien-7-one
C21H30N4O3 (386.23177899999996)
N-[[(2S,3R,4R)-1-[cyclobutyl(oxo)methyl]-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-N-(2-methylpropyl)propanamide
N-[[(2S,3S,4S)-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-2-methoxy-N-propan-2-ylacetamide
N-[[(2S,3R,4S)-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-2-methoxy-N-propan-2-ylacetamide
N-[[(2R,3S,4R)-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-2-methoxy-N-propan-2-ylacetamide
6-[4-[1-[(3S)-3-hydroxycyclohexyl]-2H-tetrazol-1-ium-5-yl]butoxy]-3,4-dihydro-1H-quinolin-2-one
C20H28N5O3+ (386.21920380000006)
(5S,6Z,8E,12S,14Z)-5,12,20,20,20-pentahydroxyicosa-6,8,14-trienoic acid
(4S)-6-[4-(1-cyclohexyl-2H-tetrazol-1-ium-5-yl)butoxy]-4-hydroxy-3,4-dihydro-1H-quinolin-2-one
C20H28N5O3+ (386.21920380000006)
6-[4-[1-(3-hydroxycyclohexyl)-2H-tetrazol-1-ium-5-yl]butoxy]-3,4-dihydro-1H-quinolin-2-one
C20H28N5O3+ (386.21920380000006)
[3-carboxy-2-[(Z)-3-hydroxytetradec-9-enoyl]oxypropyl]-trimethylazanium
C21H40NO5+ (386.29063300000007)
[(1S)-3-carboxy-1-[(Z)-3-hydroxytetradec-5-enoyl]oxypropyl]-trimethylazanium
C21H40NO5+ (386.29063300000007)
[(6S,8R,9R,10R,13S,14S,17S)-17-acetyl-6,10,13-trimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate
(1R,2S,5R)-5-Methyl-2-(1-methyl-1-(2-naphthyl)ethyl)-cyclohexane-1-YL benzoate
(1-Hydroxy-3-propanoyloxypropan-2-yl) hexadecanoate
(1-Butanoyloxy-3-hydroxypropan-2-yl) pentadecanoate
(1-Hydroxy-3-pentanoyloxypropan-2-yl) tetradecanoate
[1-carboxy-3-[3-[(4E,7E)-deca-4,7-dienoyl]oxy-2-hydroxypropoxy]propyl]-trimethylazanium
C20H36NO6+ (386.25424960000004)
(22E)-1alpha,3beta-Dihydroxychola-5,16,22-trien-24-oic Acid
3alpha-Hydroxy-12-oxo-5beta-chola-7,9(11)-dien-24-oic Acid
yanuthone K
A class I yanuthone that is 5,6-epoxy-cyclohex-2-en-1-one which is substituted at positions 3, 4, and 6 by methyl, acetoxy, and trans,trans-farnesyl groups, respectively (the R,R,R stereoisomer). Isolated from the filamentous fungus Aspergillus niger, it shows antifungal activity towards the pathogenic yeast Candida albicans (IC50 = 17.5 +-3.9 muM).
mbas#10
A 4-O-[(E)-2-methyl-2-butenoyl]ascaroside derived from (8R)-8-hydroxynonanoic acid. It is a metabolite of the nematode Caenorhabditis elegans.
TG(18:0)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
[(3s,5s)-3,5-dimethyl-5-[(5e,9e)-2-methyl-10-phenyldeca-5,9-dien-1-yl]-1,2-dioxolan-3-yl]acetic acid
(2s,3s)-3-{[(1s)-1-[bis(4-aminobutyl)carbamoyl]-3-methylbutyl]-c-hydroxycarbonimidoyl}oxirane-2-carboxylic acid
10-hydroxy-16-isopropyl-1,5,9,13-tetramethyl-6-oxapentacyclo[10.7.0.0²,⁹.0⁵,⁷.0¹³,¹⁷]nonadec-17-en-8-one
(6e,8e,11e,14e)-4,6,8,10,12,14,16-heptamethyloctadeca-6,8,11,14-tetraene-3,5,13-trione
(1s,3r,4r,6r,7s,8s,9r,10r,13r,14r,16s)-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecane-3,4,6,7,9,14,16-heptol
1,2,4-trimethyl (1s)-1-(dec-9-en-1-yl)-2-hydroxybutane-1,2,4-tricarboxylate
3-(acetyloxy)-2,2,5,8-tetramethyl-3,3a,3a¹,4,5,5a,6,7,8,9-decahydro-1h-pyren-4-yl acetate
(2s,3r,4r,5r,6s)-2-({2-[(2r,4ar,8r,8ar)-8-hydroxy-4a,8-dimethyl-octahydronaphthalen-2-yl]propan-2-yl}oxy)-6-methyloxane-3,4,5-triol
(1's,2r,4's,5'r,9's,10'r,13'r)-5',9'-dimethylspiro[oxirane-2,14'-tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan]-5'-ylmethyl (2z)-2-methylbut-2-enoate
(1s,3r,4s,6r,7r,8r,9s,10r,13r,14s,16r)-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecane-3,4,6,7,9,14,16-heptol
5-(hydroxymethyl)-3-(icos-15-en-11,13-diyn-1-yl)oxolan-2-one
4-hydroxy-4,6-dimethyl-6-(12-phenyldodec-10-en-1-yl)oxan-2-one
2-[(4z,8s,10e)-5-(hydroxymethyl)-11-methyl-14-oxabicyclo[11.2.1]hexadeca-1(15),4,10,13(16)-tetraen-8-yl]prop-2-en-1-yl butanoate
[9-(acetyloxy)-7-isopropyl-1,4a-dimethyl-2,3,4,9,10,10a-hexahydrophenanthren-1-yl]methyl acetate
(1r,3s,4r,6r,7s,11s,12r)-4,6-dihydroxy-1,4-dimethyl-12-[(2s)-6-methylhepta-3,5-dien-2-yl]tricyclo[9.3.0.0³,⁷]tetradec-8-ene-8-carbaldehyde
4-hydroxy-5-methyl-2-(3,7,11-trimethyl-9-oxododeca-2,7-dien-1-yl)phenyl acetate
1-acetyl-7-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthrene-3,10-dione
(1s,3ar,5ar,7s,9as,11ar)-1-acetyl-7-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthrene-3,10-dione
(1r,2s,4s,4as,8s,8as)-4,8-dihydroxy-2-isopropyl-4a,8-dimethyl-octahydronaphthalen-1-yl (2e)-3-phenylprop-2-enoate
4-[(7-isopropyl-1,4a-dimethyl-2,3,4,9,10,10a-hexahydrophenanthren-1-yl)methoxy]-4-oxobutanoic acid
(5as,5br,7as,11as,11br,13r,13as)-13-hydroxy-5b,8,8,11a,13a-pentamethyl-3h,4h,5h,5ah,6h,7h,7ah,9h,10h,11h,11bh,12h,13h-chryseno[1,2-c]furan-1-one
3-{1-hydroxy-2-[2,3,6-trihydroxy-2-(hydroxymethyl)-5,5,8a-trimethyl-hexahydro-1h-naphthalen-1-yl]ethyl}oxolan-2-one
(2s,3s,3ar,5as,9as,9br)-3-[(2s)-2-(furan-3-yl)-2-hydroxyethyl]-2,3a,6,6,9a-pentamethyl-octahydro-1h-cyclopenta[a]naphthalene-2-carbaldehyde
(1r,4s,6r,9r,10s,13r,15r)-6-hydroxy-5,5,9-trimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-15-yl (2z)-2-methylbut-2-enoate
(1r,2s,4ar,5r,8s,8as)-5,8-dihydroxy-2-isopropyl-4a,8-dimethyl-octahydronaphthalen-1-yl (2e)-3-phenylprop-2-enoate
(4s,6e,8e,10s,11e,14e,16s)-4,6,8,10,12,14,16-heptamethyloctadeca-6,8,11,14-tetraene-3,5,13-trione
5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecane-3,4,6,7,9,14,16-heptol
(1r,2r,6r)-3-methyl-5-oxo-6-(3,7,11-trimethyldodeca-2,6,10-trien-1-yl)-7-oxabicyclo[4.1.0]hept-3-en-2-yl acetate
(1r,5as,5br,7as,11as,11br,13as,13bs)-1-hydroxy-5b,8,8,11a,13a-pentamethyl-1h,3h,5h,5ah,6h,7h,7ah,9h,10h,11h,11bh,12h,13bh-chryseno[1,2-c]furan-13-one
(1s,2r,4r,5s,11s,14s,17r,18s)-11-(hydroxymethyl)-17-isopropyl-4,14-dimethylpentacyclo[9.7.0.0²,⁴.0⁵,⁹.0¹⁴,¹⁸]octadec-8-ene-8-carboxylic acid
(8as,9r,10as)-7-isopropyl-2,2,4,4,10a-pentamethyl-9-(2-methylpropyl)-7,8,8a,9-tetrahydroxanthene-1,3-dione
(2z,12z,14e)-16-(3,5-dihydroxyphenyl)-2-ethylidenehexadeca-12,14-dienoic acid
n-{1-[1-(dimethylamino)ethyl]-9a,11a-dimethyl-6-oxo-1h,2h,3h,3ah,3bh,4h,5h,5ah,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl}carboximidic acid
C24H38N2O2 (386.29331279999997)